|
More Support For LysoSENS
(Wednesday October 25 2006)
 | The LysoSENS bioremediation research initially funded by the Methuselah Foundation is attracting more resources: "The Biodesign Institute at Arizona State University has awarded biochemist John Schloendorn a $30,000 scholarship that will enable him to pursue anti-aging research as a Ph.D. student in the School of Life Sciences. ... Schloendorn's pioneering work [focuses] on identifying microbes that possess particularly effective mechanisms to biodegrade the molecular 'junk' that accumulates inside cells over time, and is at the root of many of the debilities caused by aging. ... Schloendorn's work has led to the isolation and characterization of bacteria that efficiently degrade several recalcitrant cholesterol breakdown products, among them 7-ketocholesterol, that are thought to play a major role in atherosclerosis (the cause of almost all heart attacks and strokes). His future objective is to isolate the enzymes responsible for the breakdown [with] the ultimate goal of creating medical bioremediation treatments for humans." |
|
